Exelixis
EXEL
#1619
Rank
NZ$23.68 B
Marketcap
NZ$94.22
Share price
0.68%
Change (1 day)
31.08%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company